Four of these genes (BMP4, CALCA, CDKN2B, and RARB) were consistent with those identified in the EWOG-MDS report, which described that CpG hypermethylation of these four genes was significantly associated with poor prognosis in JMML. The gene discussed is CALCA; the disease is myelodysplastic syndrome.